TriSalus Life [TLSI] vs Boston Scientific [BSX] Detailed Stock Comparison
TriSalus Life
NASDAQ
Loading...
Boston Scientific
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: TriSalus Life wins in 10 metrics, Boston Scientific wins in 8 metrics, with 0 ties. TriSalus Life appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | TriSalus Life | Boston Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.09 | 57.93 | TriSalus Life |
| Price-to-Book Ratio | -7.83 | 6.43 | TriSalus Life |
| Debt-to-Equity Ratio | -1.73 | 53.09 | TriSalus Life |
| PEG Ratio | 0.00 | 0.40 | TriSalus Life |
| EV/EBITDA | -7.85 | 33.14 | TriSalus Life |
| Profit Margin (TTM) | -86.61% | 13.55% | Boston Scientific |
| Operating Margin (TTM) | -65.39% | 18.63% | Boston Scientific |
| EBITDA Margin (TTM) | N/A | 18.63% | N/A |
| Return on Equity | 128.34% | 11.55% | TriSalus Life |
| Return on Assets (TTM) | -52.51% | 5.39% | Boston Scientific |
| Free Cash Flow (TTM) | $-41.19M | $2.37B | Boston Scientific |
| 1-Year Return | 9.20% | 11.02% | Boston Scientific |
| Price-to-Sales Ratio (TTM) | 6.40 | 7.80 | TriSalus Life |
| Enterprise Value | $237.56M | $155.93B | Boston Scientific |
| EV/Revenue Ratio | 6.60 | 8.43 | TriSalus Life |
| Gross Profit Margin (TTM) | 83.93% | 67.65% | TriSalus Life |
| Revenue per Share (TTM) | $1 | $13 | Boston Scientific |
| Earnings per Share (Diluted) | $-1.15 | $1.68 | Boston Scientific |
| Beta (Stock Volatility) | 0.47 | 0.61 | TriSalus Life |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
TriSalus Life vs Boston Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| TriSalus Life | 0.22% | -0.86% | -7.58% | -6.65% | -10.10% | -7.03% |
| Boston Scientific | -0.64% | -0.35% | -10.58% | -6.87% | 5.64% | 8.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| TriSalus Life | 9.20% | -53.47% | -55.14% | -55.14% | -55.14% | -55.14% |
| Boston Scientific | 11.02% | 141.87% | 151.56% | 466.49% | 1,472.36% | 305.28% |
News Based Sentiment: TriSalus Life vs Boston Scientific
TriSalus Life
News sentiment data is not available for TriSalus Life at this time.
Boston Scientific
News based Sentiment: POSITIVE
October brought a wave of positive signals for Boston Scientific, including increased institutional investment, raised price targets from multiple firms, and a promising long-range plan. While insider selling remains a point to watch, the overall narrative is one of strong growth potential and investor confidence.
Performance & Financial Health Analysis: TriSalus Life vs Boston Scientific
| Metric | TLSI | BSX |
|---|---|---|
| Market Information | ||
| Market Cap | $232.86M | $144.20B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 75,620 | 12,773,240 |
| 90 Day Avg. Volume | 119,920 | 10,174,867 |
| Last Close | $4.63 | $96.70 |
| 52 Week Range | $3.42 - $5.88 | $80.64 - $109.50 |
| % from 52W High | -21.26% | -11.69% |
| All-Time High | $12.83 (Aug 07, 2023) | $109.50 (Sep 09, 2025) |
| % from All-Time High | -63.91% | -11.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.52% | 0.23% |
| Quarterly Earnings Growth | 0.52% | 1.46% |
| Financial Health | ||
| Profit Margin (TTM) | -0.87% | 0.14% |
| Operating Margin (TTM) | -0.65% | 0.19% |
| Return on Equity (TTM) | 1.28% | 0.12% |
| Debt to Equity (MRQ) | -1.73 | 53.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.51 | $15.14 |
| Cash per Share (MRQ) | $0.53 | $0.36 |
| Operating Cash Flow (TTM) | $-28,373,000 | $4.28B |
| Levered Free Cash Flow (TTM) | $-17,734,750 | $2.94B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: TriSalus Life vs Boston Scientific
| Metric | TLSI | BSX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.09 | 57.93 |
| Forward P/E | -3.92 | 34.88 |
| PEG Ratio | 0.00 | 0.40 |
| Price to Sales (TTM) | 6.40 | 7.80 |
| Price to Book (MRQ) | -7.83 | 6.43 |
| Market Capitalization | ||
| Market Capitalization | $232.86M | $144.20B |
| Enterprise Value | $237.56M | $155.93B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.60 | 8.43 |
| Enterprise to EBITDA | -7.85 | 33.14 |
| Risk & Other Metrics | ||
| Beta | 0.47 | 0.61 |
| Book Value per Share (MRQ) | $-0.51 | $15.14 |
Financial Statements Comparison: TriSalus Life vs Boston Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TLSI | BSX |
|---|---|---|
| Revenue/Sales | $11.21M | $4.66B |
| Cost of Goods Sold | $1.80M | $1.45B |
| Gross Profit | $9.41M | $3.21B |
| Research & Development | $3.92M | $443.00M |
| Operating Income (EBIT) | $-7.33M | $937.00M |
| EBITDA | $-7.07M | $1.23B |
| Pre-Tax Income | $-8.29M | $805.00M |
| Income Tax | $-3,000 | $133.00M |
| Net Income (Profit) | $-8.29M | $672.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TLSI | BSX |
|---|---|---|
| Cash & Equivalents | $13.00M | $725.00M |
| Total Current Assets | $25.10M | $7.34B |
| Total Current Liabilities | $11.75M | $5.06B |
| Long-Term Debt | $33.00M | $10.93B |
| Total Shareholders Equity | $-34.37M | $22.45B |
| Retained Earnings | $-289.92M | $3.35B |
| Property, Plant & Equipment | $3.11M | $448.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TLSI | BSX |
|---|---|---|
| Operating Cash Flow | $-6.00M | $513.00M |
| Capital Expenditures | $-714,000 | $-187.00M |
| Free Cash Flow | $-5.25M | $277.00M |
| Debt Repayment | $-71,000 | $-1.31B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TLSI | BSX |
|---|---|---|
| Shares Short | 515,433 | 19.02M |
| Short Ratio | 4.90 | 2.76 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 75,620 | 12,773,240 |
| Average Daily Volume (90 Day) | 119,920 | 10,174,867 |
| Shares Outstanding | 31.28M | 1.47B |
| Float Shares | 39.49M | 1.48B |
| % Held by Insiders | 0.40% | 0.00% |
| % Held by Institutions | 0.17% | 0.94% |
Dividend Analysis & Yield Comparison: TriSalus Life vs Boston Scientific
| Metric | TLSI | BSX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |